Immunic, Inc.
Immunic, Inc. scores highest on Torque (51) and lowest on Anchor (33). Its PosiPenta is 39.67 out of 100, weaker than most similar companies.
On the Penta Grid this week, Immunic, Inc. is Grid #554 of 837 in the Healthcare sector in United States, and Grid #2,916 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Immunic, Inc. | 39.67 | 43 | 33 | 40 | 51 | 33 |
| PMV Pharmaceuticals, Inc. | 46.30 | 36 | 42 | 57 | 60 | 37 |
| Vivani Medical, Inc. | 34.40 | 13 | 45 | 53 | 16 | 45 |
| Coya Therapeutics, Inc. | 45.28 | 26 | 28 | 49 | 65 | 58 |
| Stereotaxis, Inc. | 32.77 | 12 | 58 | 19 | 27 | 48 |
| Polaryx Therapeutics, Inc. | 40.50 | 8 | 72 | 4 | 59 | 60 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.82 |
| P/B ratio | 0.75 |
EEarnings
| Trailing EPS | ₹-362.76 |
| Forward EPS | ₹-229.87 |
NNitro
| Price | 660.16 |
| 52-week high | 1650.88 |
| 52-week low | 479.26 |
| Fall from 52-week high | 60.0% |
TTorque
| Return on equity (ROE) | -138.17% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.45 |
| Market cap | ₹900 Cr |
| Insider holding | 0.97% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Immunic, Inc.'s PosiPenta score?
Immunic, Inc.'s PosiPenta is 39.67 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Immunic, Inc. stand on the Penta Grid?
On the Penta Grid this week, Immunic, Inc. is Grid #554 of 837 in the Healthcare sector in United States, and Grid #2,916 of 4,000 in United States.
Which PosiPenta pillar is strongest for Immunic, Inc.?
Torque (durability), with a score of 51 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Immunic, Inc.?
Anchor (stability and dividends), with a score of 33 out of 100: weaker than most similar companies.
Has Immunic, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.99 points, from 35.68 to 39.67.
PositoAI is for research and education only and is not investment advice.